GEN - Genesis Healthcare, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/6/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
106.68M138.87M270.53M183.04M200.73M
Enterprise Value 3
4.36B4.30B4.66B4.62B4.67B
Trailing P/E
1.318.43N/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
0.030.030.050.020.03
Price/Book (mrq)
N/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
0.973.944.104.124.08
Enterprise Value/EBITDA 6
12.4532.65102.0129.4445.75

Trading Information

Stock Price History

Beta (5Y Monthly) 1.31
52-Week Change 3-42.52%
S&P500 52-Week Change 36.72%
52 Week High 31.8600
52 Week Low 30.5800
50-Day Moving Average 30.8182
200-Day Moving Average 31.1312

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 31.01M
Shares Outstanding 5110.12M
Float 71.45M
% Held by Insiders 143.43%
% Held by Institutions 134.42%
Shares Short (Jun 14, 2020) 43.63M
Short Ratio (Jun 14, 2020) 41.98
Short % of Float (Jun 14, 2020) 44.64%
Short % of Shares Outstanding (Jun 14, 2020) 42.18%
Shares Short (prior month May 14, 2020) 42.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 210:11
Last Split Date 3Apr 03, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 1.41%
Operating Margin (ttm)1.11%

Management Effectiveness

Return on Assets (ttm)0.67%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.5B
Revenue Per Share (ttm)41.33
Quarterly Revenue Growth (yoy)-6.00%
Gross Profit (ttm)2.08B
EBITDA 160.94M
Net Income Avi to Common (ttm)63.39M
Diluted EPS (ttm)0.3960
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.5M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)4.28B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.79
Book Value Per Share (mrq)-6.68

Cash Flow Statement

Operating Cash Flow (ttm)-4.06M
Levered Free Cash Flow (ttm)-250.14M